sábado, 20 de diciembre de 2025

Editorial p1 Turning policy into action for brain health The Lancet Neurology +++ +...

Azathioprine for the treatment of early Parkinson's disease (AZA-PD): a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(25)00386-2/fulltext?dgcid=hubspot_update_feature_updatealerts_laneur&utm_campaign=update-laneur&utm_medium=email&_hsenc=p2ANqtz--C4hczGmVdXlcmcdW6Yg16xrTGqF5t1vXghIfIZjUmUv-kPI3oMMj3UpCyklcM8Ks4zaUXkb0_n7nBO3BbVwNONu1s3A&_hsmi=395117155&utm_content=395108665&utm_source=hs_email Seizure-related biomarkers of sudden unexpected death in epilepsy (SUDEP) in drug-resistant focal epilepsy (REPO2MSE): a prospective, multicentre case–control study https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(25)00379-5/fulltext?dgcid=hubspot_update_feature_updatealerts_laneur&utm_campaign=update-laneur&utm_medium=email&_hsenc=p2ANqtz--2Qir_Kag4S30b-jCQR2M0StqZeVbpMlz-qvSkO7yaQ8UrGiY4LMXqOKihPXhT9SSFmX07WXmOa_dBOElo_qZi29teCQ&_hsmi=395117155&utm_content=395108665&utm_source=hs_email Endovascular thrombectomy for acute stroke: evolving eligibility criteria and adjunct therapies https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(25)00356-4/abstract?utm_campaign=update-laneur&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_laneur&_hsenc=p2ANqtz-9Ww4b67TfrrvF8J_V-wrRbrONovM7RIrF4z9HLLSmiceMGFAt0RUsKGxw1RJZ80lwemCM30GLTWsB4wVvtddVKtB2-HQ&_hsmi=395117155&utm_content=395108665&utm_source=hs_email Editorial p1 Turning policy into action for brain health The Lancet Neurology https://www.thelancet.com/journals/laneur/issue/vol25no1/PIIS1474-4422(25)X0013-2

No hay comentarios:

Publicar un comentario